The Australian and New Zealand Lymphoma and Related Diseases Registry (LaRDR) is an initiative to improve the treatment and outcomes of patients with lymphoma.

The registry includes all new cases of lymphomas at participating hospital sites. National representative data on diagnosis and treatment are collected, allowing the LaRDR team to

• Understand access to care
• Monitor trends in practice, outcomes and survival
• Explore variation in factors that influence outcomes, including survival and quality of life
• Benchmark outcomes nationally and internationally
• Act as a resource for clinical trials